Biodesix announces third quarter 2023 results and highlights

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the third quarter ended september 30, 2023 and provided a corporate update. “i am pleased to announce yet another impressive quarter of growth at biodesix,” said scott hutton, president and chief executive officer. “the team delivered over 10,400 lung diagnostics tests, growing 60% over the 6,500 tests delive.
BDSX Ratings Summary
BDSX Quant Ranking